Abstract | OBJECTIVE: Aromatization is the biochemical process in which aromatase catalyzes the conversion of testosterone into estradiol, the fundamental pathway for the synthesis of estrogens. When enhanced, it can lead to hyperestrogenism, a well-known risk factor for gynecological cancers. METHODS: The surgical specimens, coming from 2 postmenopausal women with hyperestrogenism on pap smear and bioptic diagnosis of endometrial endometrioid carcinoma, were fixed in 10% neutral buffered formalin, paraffin embedded, and then submitted for routine hematoxylin/ eosin staining and immunohistochemical characterization for antiestrogen, antiprogesterone, antitesterone, anti-MLH1, anti-PMS2, anti-MSH2, and anti-MSH6. RESULTS: CONCLUSIONS: This synchronous triad underlines the importance of aromatization and hyperestrogenism in the development of gynecological malignancies in which the immunohistochemical detection of an active source of hormone production - to always keep in consideration during synchronous diseases - can guide subsequent antihormone chemotherapy based on aromatase inhibitors.
|
Authors | Luca Roncati, Antonio Manenti, Teresa Pusiol, Francesco Piscioli, Giuseppe Barbolini, Antonio Maiorana |
Journal | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
(Int J Gynecol Cancer)
Vol. 26
Issue 8
Pg. 1461-4
(10 2016)
ISSN: 1525-1438 [Electronic] England |
PMID | 27465894
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Testosterone
- Estradiol
- Aromatase
- CYP19A1 protein, human
|
Topics |
- Aromatase
(metabolism)
- Brenner Tumor
(metabolism, surgery)
- Carcinoma, Endometrioid
(metabolism, surgery)
- Endometrial Neoplasms
(metabolism, surgery)
- Endometriosis
(metabolism, surgery)
- Estradiol
(metabolism)
- Female
- Humans
- Immunohistochemistry
- Middle Aged
- Ovarian Neoplasms
(metabolism, surgery)
- Testosterone
(metabolism)
|